Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01851772 · ClinicalTrials.gov registry record · NA
Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer
A NA study, sponsored by Xoft.
- Completed
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT01851772 is a NA study that has completed, run by Xoft. The registered enrollment target is 3 participants.
The verdict
NCT01851772, a NA study, has completed, sponsored by Xoft.
- COMPLETED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety, performance and usability of the Xoft Axxent Electronic Brachytherapy System and Cervical Applicator as incorporated into the physician's current standard treatment practice and in replacement of high-dose-rate after-loaders using Iridium-192 or low-dose-rate Cesium treatments. Data will be collected on treatment delivery, safety, and acute toxicity. Our hypothesis is that the treatment is safe as incorporated into the physician's current standard of practice.
Interventions
- DEVICE Treatment with Electronic Brachytherapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2013-11 |
| Est. Completion | 2015-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01851772
The ClinicalTrials.gov registry entry for NCT01851772 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Xoft, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Treatment with Electronic Brachytherapy is the first listed.
NCT01851772 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01851772 about?
NCT01851772 is a clinical study titled "Feasibility Study of the Xoft® Axxent® Electronic Brachytherapy System for the Treatment of Cervical Cancer". The purpose of this study is to evaluate the safety, performance and usability of the Xoft Axxent Electronic Brachytherapy System and Cervical Applicator as incorporated into the physician's current standard treatment practice and in replacement of high-dose-rate after-loaders using Iridium-192 or l...
What is the current status of trial NCT01851772?
This trial is currently completed. It is a NA study. The enrollment target is 3 participants. The study started on 2013-11. Estimated completion is 2015-06.
What interventions are being tested in trial NCT01851772?
The interventions under investigation include: Treatment with Electronic Brachytherapy (DEVICE).
Who is sponsoring clinical trial NCT01851772?
This trial is sponsored by Xoft, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.